Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter A. Forsberg, MD
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Oncology Associates
Tucson, Arizona, United States
Recruiting - Colorado Blood Cancer Institute
Denver, Colorado, United States
Recruiting - Rocky Mountain Cancer Center
Denver, Colorado, United States
Recruiting - Medical Oncology Hematology Consultants
Newark, Delaware, United States
Recruiting - Florida Cancer Specialists
Lake Mary, Florida, United States
Withdrawn - Maryland Oncology Hematology
Columbia, Maryland, United States
Recruiting - Minnesota Oncology Hematology
Minneapolis, Minnesota, United States
Recruiting - Virginia Oncology Associates
Elizabeth City, North Carolina, United States
Recruiting - Oncology Hematology Care
Cincinnati, Ohio, United States
Recruiting - Oncology Associates of Oregon
Eugene, Oregon, United States
Recruiting - Tristar Bone Marrow Transplant
Nashville, Tennessee, United States
Recruiting - Vanderbilt- Ingram Cancer Center
Nashville, Tennessee, United States
Recruiting - Texas Oncology
Austin, Texas, United States
Recruiting - Texas Oncology - San Antonio
San Antonio, Texas, United States
Recruiting - Texas Oncology - Northeast Texas
Tyler, Texas, United States
Recruiting - Virginia Cancer Specialists
Fairfax, Virginia, United States
Recruiting - Blue Ridge Cancer Center
Roanoke, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Oct 2023
- Primary completion
- 31 Aug 2027
- Completion
- 31 Oct 2027
- Last update posted
- 22 Apr 2026
- Registered enrollment
- 100
- Registry id
- NCT05972135
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.